Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Abcur AB v Apoteket Farmaci AB and Apoteket AB (C-544/13, C-545/13)
Judgment
Considerations of the questions referred
The second question in Case C‑545/13
76

Abcur AB v Apoteket Farmaci AB and Apoteket AB (C-544/13, C-545/13)

Judgment of 16 Jul 2015law://eu/cjeu/2013/c-544-13/para_76@2026-11-10

76Directive 2001/83 forms part of the EU provisions relating to health, recital 2 in the preamble to that directive recalling that safeguarding public health must be the essential aim of any rules governing the production, distribution and use of medicinal products.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Court: Court of Justice · Third Chamber
Cases: C-544/13, C-545/13 · ECLI:EU:C:2015:481
Decided: 16 Jul 2015
Procedure: Preliminary reference · referred by the Stockholms tingsrätt (Sweden)
Applicant: Abcur AB
Defendants: Apoteket Farmaci AB; and; Apoteket AB and Apoteket Farmaci AB
Rapporteur: M. Ilešič
Advocate General: M. Szpunar
Bench: 5 judges
M. Ilešič, A. Ó Caoimh, C. Toader, E. Jarašiūnas, C.G. Fernlund
Language: Swedish
Official: CURIA · EUR-Lex 62013CJ0544

Topics

Pharmaceutical and cosmetic products

History · 1 version

16 Jul 2015Reading

Connections

Interprets 3: Directive 2005/29/EC; Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use; Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)
Cited by 16: Autorità Garante della Concorrenza e del Mercato v Wind Tre SpA and Vodafone Italia SpA (C-54/17, C-55/17); Criminal proceedings against X (C-390/18); A v O and G.W. and E..S. v A. Towarzystwo Ubezpieczeń Życie S.A (C-143/20); this act6 provisions; Associação Peço a Palavra and Others v Conselho de Ministros (C-563/17); Almirall BV and Almirall SA v Infinity Pharma BV and Pharmaline BV (C-589/24); Konsumentombudsmannen v Mezina AB (C-363/19); UB v Generálny riaditeľ Sociálnej poisťovne Bratislava (C-447/18); Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and Others (C-29/17)2 provisions; F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato (C-179/16); Hummel Holding A/S v Nike Inc. and Nike Retail B.V (C-617/15); LEK Farmacevtska Družba d.d. v Republika Slovenija (C-700/15)2 provisions; Hecht-Pharma GmbH v Hohenzollern Apotheke, Winfried Ertelt (C-276/15)2 provisions; Barlis 06 – Investimentos Imobiliários e Turísticos SA v Autoridade Tributária e Aduaneira (C-516/14); Citroën Commerce GmbH v Zentralvereinigung des Kraffahrzeuggewerbes zur Aufrechterhaltung lauteren Wettbewerbs eV (ZLW) (C-476/14); Silvia Ciup v Administrația Județeană a Finanțelor Publice (AJFP) Timiș - Direcția Generală Regională a Finanțelor Publice (DGRFP) Timișoara (C-288/14)
Cites 24: Treaty on the Functioning of the European Union (consolidated 2016); Directive 2005/29/EC; Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use; Ekro BV Vee- en Vleeshandel v Produktschap voor Vee en Vlees (C-327/82); Mediaprint Zeitungs- und Zeitschriftenverlag GmbH & Co. KG v "Österreich"-Zeitungsverlag GmbH (C-540/08); Gintec International Import-Export GmbH v Verband Sozialer Wettbewerb eV (C-374/05); Sevda Aykul v Land Baden-Württemberg (C-260/13); Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance); Hecht-Pharma GmbH v Staatliches Gewerbeaufsichtsamt Lüneburg (C-140/07); Staat der Nederlanden v Antroposana, Patiëntenvereniging voor Antroposofische Gezondheidszorg and Others (C-84/06); eco cosmetics GmbH & Co. KG and Raiffeisenbank St. Georgen reg. Gen. mbH v Virginie Laetitia Barbara Dupuy and Tetyana Bonchyk (C-119/13, C-120/13); Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM) and Ministère des Affaires sociales et de la Santé (C-512/12); Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products; Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products; A (C-523/07); European Commission v Republic of Poland (C-185/10); Novartis Pharma GmbH v Apozyt GmbH (C-535/11); Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance); Erotic Center BVBA v Belgische Staat (C-3/09); Abcur AB v Apoteket Farmaci AB and Apoteket AB (C-544/13); Council Directive 89/341/EEC of 3 May 1989 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products; Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance); Subdelegación del Gobierno en Guipuzkoa - Extranjeria v Samir Zaizoune (C-38/14); Directive 2006/114/EC of the European Parliament and of the Council of 12 December 2006 concerning misleading and comparative advertising (codified version) (Text with EEA relevance)